These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12085678)

  • 1. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women.
    Grigoriadis S; Seeman MV
    Can J Psychiatry; 2002 Jun; 47(5):437-42. PubMed ID: 12085678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.
    Bergemann N; Parzer P; Jaggy S; Auler B; Mundt C; Maier-Braunleder S
    Schizophr Bull; 2008 Nov; 34(6):1172-81. PubMed ID: 18156639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen effects in schizophrenia and their potential therapeutic implications--review.
    Riecher-Rössler A
    Arch Womens Ment Health; 2002 Nov; 5(3):111-8. PubMed ID: 12510214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating schizophrenia during menopause.
    Brzezinski A; Brzezinski-Sinai NA; Seeman MV
    Menopause; 2017 May; 24(5):582-588. PubMed ID: 27824682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms?
    Lindamer LA; Buse DC; Lohr JB; Jeste DV
    Biol Psychiatry; 2001 Jan; 49(1):47-51. PubMed ID: 11163779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogen treatment for women with schizophrenia.
    Aust Nurs Midwifery J; 2014 Jul; 22(1):42. PubMed ID: 25093237
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phases of the menstrual cycle and therapeutic response to neuroleptic therapy in patients with schizophrenia].
    Vanurová I; Yamamotová A
    Cas Lek Cesk; 2001 Oct; 140(21):668-70. PubMed ID: 11766456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics.
    Bergemann N; Mundt C; Parzer P; Jannakos I; Nagl I; Salbach B; Klinga K; Runnebaum B; Resch F
    Schizophr Res; 2005 Mar; 73(2-3):357-66. PubMed ID: 15653282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
    Chan J; Sweeting M
    J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogens and the gonadal axis. Implications for women with schizophrenia].
    Riecher-Rössler A
    Nervenarzt; 2003 May; 74(5):398-405. PubMed ID: 12966813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study.
    Bergemann N; Mundt C; Parzer P; Pakrasi M; Eckstein-Mannsperger U; Haisch S; Salbach B; Klinga K; Runnebaum B; Resch F
    Schizophr Res; 2005 May; 74(2-3):125-34. PubMed ID: 15721993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens and men with schizophrenia: is there a case for adjunctive therapy?
    Kulkarni J; de Castella A; Headey B; Marston N; Sinclair K; Lee S; Gurvich C; Fitzgerald PB; Burger H
    Schizophr Res; 2011 Feb; 125(2-3):278-83. PubMed ID: 21062669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia after forty and its relation with estrogens].
    Peña Salas GF; Gaviria SL
    Vertex; 2013; 24(111):325-32. PubMed ID: 24312916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC; Honer WG
    J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
    [No Abstract]   [Full Text] [Related]  

  • 19. Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study.
    Bergemann N; Parzer P; Kaiser D; Maier-Braunleder S; Mundt C; Klier C
    Psychoneuroendocrinology; 2008 May; 33(4):507-16. PubMed ID: 18343039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.